Emergent Biosolutions

Gaithersburg, MD ManufacturingNAICS 325410

Self-funded health planPlan year 2025Renews January
1,949Participants-19% vs. prior year
$4.6MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#6 of 19Manufacturing in MDBy participants

Overview

Emergent Biosolutions sponsors a self-funded health plan that covered 1,949 participants in plan year 2025, down 19% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
1,949 · prior year 2,403
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Emergent Biosolutions Inc. Employee Benefit Plan, plan 501 (1,949 participants)
Broker compensation
$109K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Prudential Insurance Company of AmericaLife, Long-term disability540$782K$90K
American Heritage Life Insurance CompanyAccident, Critical Illness, Hospital233$135K$8K
Vision Service PlanVision458$73K$2K
TalkspaceEmployee Assistance Program991$42K—
Arag Insurance CompanyLegal330$38K$4K
Telus Health (US) Ltd.Employee Assistance Program996$20K—
Federal Insurance CompanyAccidental Death and Dismemberment996$8K—
Delta Dental of PennsylvaniaDental1,250—$6K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$4.6M/ year

Estimated prescription spend: 1,949 participants × $2,371 national average per member. Usually higher once dependents are counted.

$120K–$296K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$35K–$88K
Lower-cost therapeutic alternatives$51K–$107K
Generic pricing vs. actual cost$22K–$67K
PBM contract terms$12K–$35K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Emergent Biosolutions
Sponsor EIN
14-1902018
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 14-1902018 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Emergent Biosolutions, Inc. Employee Deferred Compensation Plan
Type
401(k) plan
Participants
1,785

About this data

Source: Emergent Biosolutions's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Emergent Biosolutions.

Request a correction · Methodology